DAWN - Day One Biopharmaceuticals, Inc. -  [ ]

Ticker Details
Day One Biopharmaceuticals, Inc.
IPO Date: May 27, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $1.21B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.42 | 2.87%
Avg Daily Range (30 D): $0.42 | 3.79%
Avg Daily Range (90 D): $0.32 | 3.41%
Institutional Daily Volume
Avg Daily Volume: .83M
Avg Daily Volume (30 D): 2.27M
Avg Daily Volume (90 D): 2.23M
Trade Size
Avg Trade Size (Sh.): 87
Avg Trade Size (Sh.) (30 D): 91
Avg Trade Size (Sh.) (90 D): 99
Institutional Trades
Total Institutional Trades: 1,747
Avg Institutional Trade: $1.61M
Avg Institutional Trade (30 D): $2.04M
Avg Institutional Trade (90 D): $2.01M
Avg Institutional Trade Volume: .13M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.86M
Avg Closing Trade (30 D): $2.88M
Avg Closing Trade (90 D): $2.37M
Avg Closing Volume: 146.87K
 
News
Feb 24, 2026 @ 9:00 PM
Day One Reports Fourth Quarter and Full Year 2025 ...
Source: Na
Jan 6, 2026 @ 2:02 PM
Day One Completes Acquisition of Mersana Therapeut...
Source: Globe Newswire
Nov 13, 2025 @ 3:15 PM
Day One Biopharma Expands Oncology Pipeline With $...
Source: Vandana Singh
Nov 13, 2025 @ 11:00 AM
Day One to Acquire Mersana Therapeutics to Advance...
Source: Day One Biopharmaceuticals
Aug 5, 2025 @ 8:00 PM
Day One Reports Second Quarter 2025 Financial Resu...
Source: Day One Biopharmaceuticals
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-1.52 $-.19 $-.29
Diluted EPS $-1.52 $-.19 $-.29
Revenue $133.67M $39.8M $33.91M
Gross Profit
Net Income / Loss $-72.79M $M $-30.32M
Operating Income / Loss $-165.62M $-24.25M $-34.97M
Cost of Revenue
Net Cash Flow $-379.49M $7.66M $-89.35M
PE Ratio